Bokf Na Buys 1,985 Shares of Tenet Healthcare Co. (NYSE:THC)

BOKF NA boosted its position in shares of Tenet Healthcare Co. (NYSE:THC - Free Report) by 22.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,004 shares of the company's stock after purchasing an additional 1,985 shares during the period. BOKF NA's holdings in Tenet Healthcare were worth $1,408,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. EverSource Wealth Advisors LLC grew its position in shares of Tenet Healthcare by 9.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 940 shares of the company's stock worth $119,000 after buying an additional 80 shares during the last quarter. GeoWealth Management LLC grew its stake in shares of Tenet Healthcare by 39.8% during the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company's stock worth $37,000 after purchasing an additional 84 shares during the period. Spire Wealth Management increased its holdings in Tenet Healthcare by 19.5% in the fourth quarter. Spire Wealth Management now owns 558 shares of the company's stock valued at $70,000 after buying an additional 91 shares in the last quarter. CIBC Private Wealth Group LLC lifted its position in shares of Tenet Healthcare by 1.7% during the 4th quarter. CIBC Private Wealth Group LLC now owns 5,619 shares of the company's stock valued at $732,000 after buying an additional 92 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its position in shares of Tenet Healthcare by 1.2% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 8,109 shares of the company's stock valued at $1,024,000 after purchasing an additional 100 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have weighed in on THC. Barclays raised their target price on shares of Tenet Healthcare from $161.00 to $171.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 30th. UBS Group boosted their price target on shares of Tenet Healthcare from $217.00 to $230.00 and gave the stock a "buy" rating in a research note on Wednesday, April 30th. Cantor Fitzgerald reiterated an "overweight" rating and issued a $177.00 target price on shares of Tenet Healthcare in a report on Thursday, February 13th. Guggenheim started coverage on Tenet Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $165.00 price target on the stock. Finally, Royal Bank of Canada upped their target price on shares of Tenet Healthcare from $183.00 to $189.00 and gave the company an "outperform" rating in a report on Wednesday, April 30th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $174.94.

Tenet Healthcare Price Performance

THC traded up $1.28 during trading on Wednesday, hitting $158.98. The company's stock had a trading volume of 910,972 shares, compared to its average volume of 1,533,472. The firm's 50 day moving average price is $130.60 and its two-hundred day moving average price is $136.09. The stock has a market capitalization of $14.77 billion, a price-to-earnings ratio of 4.93, a price-to-earnings-growth ratio of 1.02 and a beta of 1.63. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. Tenet Healthcare Co. has a 12 month low of $109.82 and a 12 month high of $171.20.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $4.36 EPS for the quarter, topping analysts' consensus estimates of $3.11 by $1.25. The business had revenue of $5.22 billion during the quarter, compared to analysts' expectations of $5.15 billion. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. The firm's quarterly revenue was down 2.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.22 earnings per share. Sell-side analysts forecast that Tenet Healthcare Co. will post 12.24 earnings per share for the current fiscal year.

Insider Transactions at Tenet Healthcare

In other news, Director J Robert Kerrey sold 5,001 shares of Tenet Healthcare stock in a transaction that occurred on Friday, May 9th. The shares were sold at an average price of $148.50, for a total value of $742,648.50. Following the completion of the sale, the director now directly owns 22,377 shares in the company, valued at approximately $3,322,984.50. The trade was a 18.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.81% of the company's stock.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.